Cost-effectiveness of rhythm control strategy: Ablation versus antiarrhythmic drugs for treating atrial fibrillation in Korea based on real-world data.

Front Cardiovasc Med · 2023 · PMC9902500 · PMID 36760559

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The authors concluded that their base case ICER was favorable for ablation-based therapy with a highly significant decrease in CV events and AF recurrences, despite a higher up-front cost for the procedure.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.